# Evidence Register: Salamander Regeneration Framework

## Purpose

This document provides a complete audit trail for every major claim in the Salamander Regeneration Framework. Each claim is classified by evidence type and current validation status. This register is the single source of truth for what is **verified**, **tested**, **estimated**, or **forecast**.

---

## Evidence Classification

| Classification | Definition | Required Before External Use |
|----------------|------------|------------------------------|
| **Verified** | Reproducible test result with CI artifact | CI artifact and reproducible run logs |
| **Tested** | Passed internal tests, not yet independently reproduced | Independent reproduction or CI artifact |
| **Estimated** | Calculated projection based on assumptions | Pilot data or benchmarked case study |
| **Forecast** | Predicted outcome based on model | Actual production data |
| **Claimed** | Asserted without current evidence | Peer review, external validation, or proof |
| **Planned** | Intended future work | Implementation and verification |

---

## Claim-by-Claim Evidence Register

### 1. Technical Performance Claims

| # | Claim | Current Value | Classification | Evidence | Required for External Use |
|---|-------|--------------|----------------|----------|---------------------------|
| 1.1 | Regeneration latency (p99) | <5 seconds | **Estimated** | Internal benchmark script | Production benchmark with CI artifact |
| 1.2 | Regeneration success rate | >95% | **Tested** | 16/16 property-based tests | Independent reproduction |
| 1.3 | Mathematical invariants proven | 16/16 | **Tested** | Hypothesis property tests | Formal proof (Lean/Coq/Isabelle) or independent review |
| 1.4 | Test coverage | 46/46 passing | **Verified** | pytest output | CI artifact with reproducible command |
| 1.5 | Memory per module | <10 KB | **Estimated** | Resource benchmark script | Standardized hardware benchmark |
| 1.6 | Throughput | >500 regen/second | **Estimated** | Throughput benchmark script | Load test with CI artifact |

### 2. Business Value Claims

| # | Claim | Current Value | Classification | Evidence | Required for External Use |
|---|-------|--------------|----------------|----------|---------------------------|
| 2.1 | Downtime reduction | 95% (2-4 hrs → <15 min/month) | **Forecast** | Industry averages (Gartner 2024) | Production incident comparison from pilot |
| 2.2 | Incident reduction | 90% (10-20 → 1-2/month) | **Forecast** | Industry averages | Pilot customer data |
| 2.3 | Annual value per enterprise | $2.3M-$4.5M | **Estimated** | $5,600/min downtime cost × estimated reduction | Customer case study with verified ROI |
| 2.4 | 12-month ROI | 1,200-1,800% | **Estimated** | Financial model with assumptions | Pilot financial data or McKinsey validation |
| 2.5 | Payback period | 2-3 months | **Estimated** | Financial model | Pilot cash flow data |
| 2.6 | TAM | $10B+ | **Estimated** | Market research (Gartner, IDC) | Third-party market analysis |
| 2.7 | On-call burden reduction | 75% | **Forecast** | Assumption based on automation | Customer operational data |

### 3. Scientific Claims

| # | Claim | Current Value | Classification | Evidence | Required for External Use |
|---|-------|--------------|----------------|----------|---------------------------|
| 3.1 | Density matrix formalism | Substrate-agnostic | **Claimed** | Mathematical derivation in docs | Peer-reviewed publication |
| 3.2 | Von Neumann entropy as blastema metric | Novel application | **Claimed** | Literature review | Citation in published paper |
| 3.3 | Innervation failure as distinct failure mode | Theoretically sound | **Claimed** | Formal specification | Peer review or formal proof |
| 3.4 | Biological-to-quantum mapping | Rigorous correspondence | **Claimed** | Mapping table in documentation | Biologist validation or publication |
| 3.5 | Malformed regeneration guard | Prevents "cancer analog" | **Tested** | Unit tests for validate_collapse_or_quarantine | Independent security audit |
| 3.6 | Refractory period prevents oscillation | Mathematically sound | **Tested** | Lindblad decay tests | Long-duration stability testing |

### 4. Security Claims

| # | Claim | Current Value | Classification | Evidence | Required for External Use |
|---|-------|--------------|----------------|----------|---------------------------|
| 4.1 | Cryptographic audit trail | HMAC-SHA256 | **Verified** | Code review of sign_regeneration_event | Third-party cryptographic audit |
| 4.2 | Rate limiting effectiveness | 5 regen/60s/module | **Tested** | Unit tests for check_rate_limit | Load test under adversarial conditions |
| 4.3 | Sensitive path protection | Blocks security/auth/payment | **Tested** | Unit tests for check_sensitive_paths | Penetration test |
| 4.4 | Immutable logs | Append-only, cryptographically chained | **Claimed** | Design documentation | Independent security audit |
| 4.5 | SOC 2 Type II readiness | Compliant | **Estimated** | Control mapping in SECURITY.md | Actual SOC 2 audit |
| 4.6 | FedRAMP readiness | In progress | **Planned** | FedRAMP package preparation | FedRAMP authorization |

### 5. Competitive Claims

| # | Claim | Current Value | Classification | Evidence | Required for External Use |
|---|-------|--------------|----------------|----------|---------------------------|
| 5.1 | Faster than Kubernetes restart | <5s vs 30-60s | **Estimated** | Benchmark guide with methodology | Head-to-head benchmark |
| 5.2 | Faster than AWS Auto Scaling | <5s vs 2-5 min | **Estimated** | Benchmark guide with methodology | Head-to-head benchmark |
| 5.3 | State preservation | 100% vs 0% | **Claimed** | Design documentation (positional memory) | Customer validation |
| 5.4 | Sub-second regeneration | <5s | **Estimated** | Internal benchmark | Production benchmark |
| 5.5 | Zero-downtime healing | Claimed | **Forecast** | Design (quarantine + regenerate in-place) | Production validation |

### 6. Mathematical/Formal Claims

| # | Claim | Current Value | Classification | Evidence | Required for External Use |
|---|-------|--------------|----------------|----------|---------------------------|
| 6.1 | Density matrix invariants | Hermitian, trace=1, PSD | **Tested** | 16 property-based tests | Formal proof in Lean/Coq/Isabelle |
| 6.2 | Entropy bounds | 0 ≤ S(ρ) ≤ log(DIM) | **Tested** | Property-based test | Formal proof |
| 6.3 | Born rule normalization | Σ P(role) = 1 | **Tested** | Property-based test | Formal proof |
| 6.4 | Lindblad trace preservation | Tr(ρ) = 1 after decay | **Tested** | Unit test | Formal proof |
| 6.5 | Pipeline correctness | Invariants preserved end-to-end | **Tested** | Integration tests | Full formal verification |
| 6.6 | Non-separability detection | PPT criterion | **Claimed** | Implementation of is_separable_approx | Validation with known entangled/separable states |

### 7. Implementation Claims

| # | Claim | Current Value | Classification | Evidence | Required for External Use |
|---|-------|--------------|----------------|----------|---------------------------|
| 7.1 | Multi-agent system | 6 specialized agents | **Verified** | Code in multi_agent/ | Integration test with all agents |
| 7.2 | Swarm intelligence | Pheromone trails, PSO | **Tested** | 27 frontier tests | Load test with 100+ agents |
| 7.3 | WebSocket streaming | Real-time events | **Tested** | Unit tests for ConnectionManager | Production load test |
| 7.4 | CEO Terminal | Live monitoring | **Claimed** | Frontend component exists | User acceptance testing |
| 7.5 | Approval workflows | Human-in-the-loop | **Tested** | API tests for approve_regeneration | Security audit |

### 8. Open Source / Community Claims

| # | Claim | Current Value | Classification | Evidence | Required for External Use |
|---|-------|--------------|----------------|----------|---------------------------|
| 8.1 | Open-source ready | MIT/Apache license | **Planned** | LICENSE file exists | Actual public release |
| 8.2 | Community contributions | CONTRIBUTING.md | **Planned** | Document written | Active community (contributors, issues) |
| 8.3 | Reproducibility | Docker, scripts | **Documented** | REPRODUCIBILITY.md | Independent reproduction success |
| 8.4 | SBOM availability | SPDX, CycloneDX | **Documented** | SBOM_TEMPLATE.md | Actual SBOM generated and validated |

---

## Evidence Gaps Analysis

### Critical Gaps (Block External Release)

| Gap | Claim Affected | Remediation | Owner | Timeline |
|-----|---------------|-------------|-------|----------|
| 1. No independent test reproduction | 1.2, 1.3, 1.4 | Run tests from clean clone, publish CI logs | Engineering | 1 week |
| 2. No formal proofs compiled | 3.1, 6.1-6.5 | Complete at least 1 proof in Lean/Coq | Research | 3 months |
| 3. No pilot customer data | 2.1-2.7, 5.3, 5.5 | Recruit 3-5 pilot customers | Customer Success | 3 months |
| 4. No third-party security audit | 4.1-4.6 | Engage NCC Group or Cure53 | Security | 2 months |
| 5. No public GitHub repo | 8.1-8.4 | Sanitize and release | Engineering | 2 weeks |

### High-Priority Gaps (Block Academic Publication)

| Gap | Claim Affected | Remediation | Owner | Timeline |
|-----|---------------|-------------|-------|----------|
| 1. No peer review | 3.1-3.5 | Submit to NSDI/SOSP/Nature | Research | 3 months |
| 2. No reproducibility validation | 3.2, 8.3 | Independent group reproduces results | Research | 3 months |
| 3. No formal verification | 6.1-6.5 | Complete proof assistant integration | Research | 6 months |

### Medium-Priority Gaps (Block Government Adoption)

| Gap | Claim Affected | Remediation | Owner | Timeline |
|-----|---------------|-------------|-------|----------|
| 1. No FedRAMP authorization | 4.6 | Begin authorization process | Compliance | 12 months |
| 2. No NCSC assessment | 4.5 | Engage NCSC for security review | Security | 6 months |
| 3. No SBOM generation | 4.4, 8.4 | Implement SBOM generator | Engineering | 1 month |

### Low-Priority Gaps (Block Commercial Claims)

| Gap | Claim Affected | Remediation | Owner | Timeline |
|-----|---------------|-------------|-------|----------|
| 1. No competitive benchmarks | 5.1-5.5 | Head-to-head vs. Kubernetes, AWS | Engineering | 2 months |
| 2. No case studies | 2.1-2.7 | Recruit customers, write case studies | Marketing | 6 months |
| 3. No Gartner briefing | 5.1-5.5 | Present to Gartner analysts | Marketing | 3 months |

---

## Recommended Actions

### Immediate (This Week)
1. **Downgrade all "Estimated" and "Forecast" claims** in public-facing documents to clearly mark them as projections
2. **Add evidence table** to SCIENTIFIC_POSITION_SALAMANDER.md and INDUSTRY_POSITION_SALAMANDER.md
3. **Create CI workflow** that runs 46/46 tests and publishes artifacts
4. **Pin all dependencies** in requirements.lock.txt

### Short-Term (This Month)
1. **Run independent test reproduction**: Fresh VM, clean clone, one-command test run
2. **Complete 1 formal proof** in Lean or Coq (even if just density matrix Hermiticity)
3. **Generate actual SBOM** using the template
4. **Engage security audit firm** (RFP process)

### Medium-Term (This Quarter)
1. **Recruit 3 pilot customers** with signed agreements
2. **Submit academic paper** to top-tier venue
3. **Complete formal verification** of core invariants
4. **Publish benchmark results** with reproducible methodology

### Long-Term (6-12 Months)
1. **Complete all formal proofs**
2. **Publish 3+ customer case studies** with verified ROI
3. **Obtain FedRAMP authorization**
4. **Achieve Gartner Magic Quadrant positioning**

---

## Claim Language Guidelines

### ✅ Approved Language

- "Tests show..." (with CI artifact)
- "Property-based testing verifies..." (with test output)
- "Mathematical formalism suggests..." (with derivation)
- "Estimated based on..." (with assumptions documented)
- "Forecast: if..." (with model and assumptions)
- "Planned: we intend to..." (with timeline)

### ❌ Prohibited Language (Without Evidence)

- "Proven to..." (unless formal proof exists)
- "Guaranteed..." (unless mathematically proven)
- "Will deliver..." (unless contractually committed)
- "Validated by..." (unless external validation exists)
- "Certified..." (unless certification obtained)
- "X% improvement" (unless measured in production)

---

## Audit Trail

| Date | Action | Document | Owner |
|------|--------|----------|-------|
| 2026-06-22 | Created evidence register | EVIDENCE_REGISTER_SALAMANDER.md | CTO Office |
| 2026-06-22 | Downgraded unverified claims | All public docs | CTO Office |
| 2026-06-22 | Added evidence tables | SCIENTIFIC_POSITION, INDUSTRY_POSITION | CTO Office |

---

## Sign-Off

**Technical Lead**: _______________ Date: _______________  
**Research Lead**: _______________ Date: _______________  
**Security Lead**: _______________ Date: _______________  
**Compliance Officer**: _______________ Date: _______________  

---

**Last Updated**: 2026-06-22  
**Next Review**: 2026-06-29 (weekly until external validation complete)  
**Owner**: CTO Office